CONA
VIVO

Capital One National Association’s Meridian Bioscience Inc VIVO Stock Holding History

Capital One National Association’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-11,450
Closed -$304K – 583
2013
Q4 		$304K Sell
11,450
-203
-2% -$4.99K 0.03% 428
2013
Q3 		$275K Buy
+11,653
New +$272K 0.03% 433

Other funds holding VIVO

BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
CPCM
Clifton Park Capital Management Wilmington, Delaware $881M AUM 5.59% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

Capital One National Association's VIVO Position: Q1 2014 in Review

Capital One National Association sold out of Meridian Bioscience Inc (VIVO) in Q1 2014, closing a stake of 11,450 shares — an estimated $304K sold.

Capital One National Association first reported a position in VIVO in Q3 2013 and held it in 2 quarters. The position peaked at $304K in Q4 2013. 166 funds tracked by Wall St. Rank hold VIVO as of Q1 2014.

  • Capital One National Association reported no remaining Meridian Bioscience Inc position as of Q1 2014 after selling out during the quarter.
  • Capital One National Association sold 11,450 Meridian Bioscience Inc shares in Q1 2014, an estimated $304K.
  • Capital One National Association first reported a position in Meridian Bioscience Inc in Q3 2013 and held it in 2 quarters.
  • Capital One National Association's Meridian Bioscience Inc position peaked at $304K in Q4 2013.
  • 166 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2014.

Based on Capital One National Association's 13F filing for Q1 2014, filed 7 May 2014.